🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/06/2011 | 6,44 | 6,51 | 6,34 | 6,41 | +0,00% | 2,52% | 487.152 |
| 16/06/2011 | 6,13 | 6,41 | 6,13 | 6,41 | +4,69% | 4,47% | 132.728 |
| 15/06/2011 | 6,31 | 6,38 | 6,09 | 6,12 | -4,29% | 4,55% | 100.989 |
| 14/06/2011 | 6,35 | 6,42 | 6,30 | 6,39 | +1,69% | 1,87% | 109.164 |
| 13/06/2011 | 6,21 | 6,37 | 6,15 | 6,29 | +2,02% | 3,52% | 167.514 |
| 10/06/2011 | 6,26 | 6,28 | 6,13 | 6,16 | -2,37% | 2,39% | 134.331 |
| 09/06/2011 | 6,24 | 6,44 | 6,24 | 6,31 | -1,56% | 3,30% | 64.601 |
| 08/06/2011 | 6,46 | 6,63 | 6,41 | 6,41 | -1,25% | 3,48% | 79.829 |
| 07/06/2011 | 6,24 | 6,58 | 6,24 | 6,49 | +1,56% | 5,40% | 57.067 |
| 06/06/2011 | 6,38 | 6,50 | 6,35 | 6,39 | +0,29% | 2,35% | 72.295 |
| 03/06/2011 | 6,36 | 6,44 | 6,31 | 6,38 | -1,35% | 2,06% | 94.577 |
| 02/06/2011 | 6,33 | 6,46 | 6,30 | 6,46 | +2,37% | 2,56% | 81.272 |
| 01/06/2011 | 6,61 | 6,66 | 6,31 | 6,31 | -4,53% | 5,28% | 149.079 |
| 31/05/2011 | 6,70 | 6,70 | 6,51 | 6,61 | -0,09% | 2,89% | 179.215 |
| 27/05/2011 | 6,69 | 6,69 | 6,53 | 6,62 | -0,75% | 2,43% | 52.258 |
| 26/05/2011 | 6,46 | 6,71 | 6,46 | 6,67 | +2,99% | 3,76% | 99.867 |
| 25/05/2011 | 6,38 | 6,54 | 6,35 | 6,48 | +0,97% | 3,03% | 109.164 |
| 24/05/2011 | 6,41 | 6,53 | 6,24 | 6,41 | +0,10% | 4,48% | 192.360 |
| 23/05/2011 | 6,58 | 6,58 | 6,26 | 6,41 | -3,84% | 4,83% | 324.928 |
| 20/05/2011 | 6,81 | 6,84 | 6,59 | 6,66 | -3,00% | 3,57% | 302.005 |
| 19/05/2011 | 6,92 | 6,92 | 6,82 | 6,87 | -0,45% | 1,53% | 137.377 |
| 18/05/2011 | 6,94 | 6,96 | 6,83 | 6,90 | -0,09% | 1,80% | 146.995 |
| 17/05/2011 | 7,01 | 7,06 | 6,77 | 6,91 | -2,38% | 4,18% | 116.218 |
| 16/05/2011 | 7,08 | 7,34 | 7,02 | 7,07 | +0,00% | 4,49% | 176.009 |
| 13/05/2011 | 7,07 | 7,29 | 6,93 | 7,07 | +0,35% | 5,12% | 187.551 |
| 12/05/2011 | 6,87 | 7,05 | 6,83 | 7,05 | +1,99% | 3,18% | 119.584 |
| 11/05/2011 | 7,18 | 7,18 | 6,77 | 6,91 | -3,57% | 5,73% | 281.807 |
| 10/05/2011 | 6,88 | 7,17 | 6,81 | 7,17 | +4,64% | 5,26% | 298.318 |
| 09/05/2011 | 6,85 | 6,91 | 6,81 | 6,85 | +0,09% | 1,37% | 100.989 |
| 06/05/2011 | 6,85 | 6,86 | 6,74 | 6,84 | +1,39% | 1,73% | 91.371 |